INS and diabetes mellitus: Within the diabetes subgroup, patients were receiving various antidiabetic treatments: metformin (n = 21), insulin (n = 9), SFN (n = 19), TZD (n = 4), DPP-4i (n = 11), GLN (n = 4), and AGi (n = 13).